Thomas A Mccourt Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

Thomas A Mccourt is Chief Executive Officer of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 1.69 Million shares of IRWD, which is worth approximately $1.03 Million. The most recent transaction as insider was on Mar 08, 2022, when has been sold 248,869 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.69M

45.38% 3M change

46.68% 12M change

Total Value Held $1.03 Million

Thomas A MCCOURT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 08 2022	BUY Grant, award, or other acquisition	-	248,869 Added 22.96%	835,189 Class A Common Stock
Feb 28 2022	SELL Open market or private sale	$521,527 $10.77 p/Share	48,424 Reduced 7.63%	586,320 Class A Common Stock
Jan 19 2022	BUY Grant, award, or other acquisition	-	60,290 Added 8.67%	634,744 Class A Common Stock
Dec 22 2021	SELL Open market or private sale	$528,591 $11.41 p/Share	46,327 Reduced 7.46%	574,454 Class A Common Stock
Nov 23 2021	SELL Open market or private sale	$609,618 $11.58 p/Share	52,644 Reduced 7.84%	618,545 Class A Common Stock
Jun 07 2021	BUY Grant, award, or other acquisition	-	104,690 Added 13.49%	671,189 Class A Common Stock
May 24 2021	SELL Open market or private sale	$21,021 $12.25 p/Share	1,716 Reduced 0.3%	566,499 Class A Common Stock
Mar 26 2021	BUY Grant, award, or other acquisition	-	96,638 Added 14.54%	568,215 Class A Common Stock
Feb 26 2021	SELL Open market or private sale	$133,780 $9.11 p/Share	14,685 Reduced 3.02%	471,577 Class A Common Stock
Feb 22 2021	BUY Grant, award, or other acquisition	-	145,631 Added 23.05%	486,262 Class A Common Stock
Dec 14 2020	SELL Payment of exercise price or tax liability	$989,286 $12.2 p/Share	81,089 Reduced 19.23%	340,631 Class A Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$988,881 $9.89 p/Share	99,988 Added 19.17%	421,720 Class A Common Stock

Also insider at

XLRN

ACCELERON PHARMA INC Healthcare

Director

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

Director

TAM

Thomas A Mccourt

Chief Executive Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Value

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

Operation

Value

Type

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Track Activities on IRWD

Account